CCM NYSE Week ended 07 Aug 2026

Weekly Investor Report

Concord Medical Services Holdings · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 4.53 USD
2.4% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 4.3% above the Trend Line and sits at 35.5% of its 52-week range. The latest completed week returned 2.4%, after a -10.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.

Setup score 29 out of 100
Latest Close 4.53 USD 7 Aug 2026
1W Return 2.4% latest completed week
4W Return -10.3% short-term follow-through
12W Return -12.4% quarterly tape
Trend Breadth 25.0% 13 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 11-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 43.34% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.4% Latest completed week; four-week move -10.3%. Indicator stack 52/38 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.34% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 4 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 4.3% above the Trend Line and sits at 35.5% of its 52-week range. The latest completed week returned 2.4%, after a -10.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4512-week average 0.48

12-week confirmation

Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.45Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -10.3% over four weeks, -12.4% over 12 weeks, and -11.2% over one year. The current trend has remained active for 11 consecutive weeks.

Performance by holding period

1W2.4%
4W-10.3%
12W-12.4%
26W19.5%
52W-11.2%
Active trend streak11 weeks
Active weeks in one year13
Trend breadth25.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.15Latest activity-pressure read.
Pressure change-119.9%Four-week change in activity pressure.
Leadership-12.74Latest relative-leadership reading.
RS change-258.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 73% Model confidence 68%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength26/100Blend of value, momentum, and quality. Underlying universe rank 75; rank 1 is best.
Value40/100Relative valuation strength. Underlying universe rank 61; rank 1 is best.
Quality37/100Profitability and accounting quality. Underlying universe rank 64; rank 1 is best.
Momentum39/100Medium-term price momentum. Underlying universe rank 62; rank 1 is best.
Growth40/100Revenue and earnings growth. Underlying universe rank 61; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.0x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-1.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
5.6%
Gross profit retained from each unit of revenue.
Operating margin
-48.0%
Operating profit retained from revenue.
Free-cash-flow margin
-24.0%
Free cash flow generated from revenue.
Return on invested capital
-13.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-46.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

0 positive · 3 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-35.1%Distance below the 52-week high.
13-week volatility9.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+45.3%Week of 8 May.
Worst week-15.4%Week of 17 Jul.
Latest week+2.4%Week of 7 Aug.

Shape of recent returns

Strong gains6
Modest gains8
Flat weeks0
Modest losses4
Sharp losses8
Recent vol9.8%13-week weekly-return volatility.
Base vol10.7%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew7.6% / -7.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape32/100

Trend, activity pressure, participation, and risk combine to a 32/100 tape read.

 Indicator analysis60/100

Latest 12-week confirmation: trend 11/12, activity pressure 11/12, relative leadership 1/12.

Activity pressure 0.45; No reversal markers Next-Week ExpectancyNegative 43.34%

Next-week expectancy is negative with a 43.34% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors34/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 53 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 4 relevant articles.

Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20264.53 USD2.4%4.34 USD6.36 USD-0.15-12.74280.6KOn
31 Jul 20264.42 USD2.9%4.35 USD6.42 USD0.14-12.33252.9KOn
24 Jul 20264.30 USD0.7%4.34 USD6.48 USD0.29-14.80272.9KOn
17 Jul 20264.27 USD-15.4%4.32 USD6.55 USD0.52-16.49368.6KOn
10 Jul 20265.05 USD15.0%4.32 USD6.62 USD0.78-3.55416.4KOn
3 Jul 20264.39 USD-6.4%4.29 USD6.67 USD0.67-15.44213.4KOn
26 Jun 20264.69 USD-11.8%4.28 USD6.73 USD0.91-8.51243.4KOn
19 Jun 20265.32 USD20.7%4.25 USD6.79 USD1.070.59223.5KOn
12 Jun 20264.41 USD-7.8%4.20 USD6.84 USD1.10-16.5434.8KOn
5 Jun 20264.78 USD-3.0%4.20 USD6.90 USD1.36-10.25389.2KOn
29 May 20264.93 USD0.4%4.21 USD6.96 USD1.42-11.07179.4KOn
22 May 20264.91 USD-5.0%4.23 USD7.02 USD1.14-11.54131.2KOff
15 May 20265.17 USD-9.9%4.23 USD7.07 USD0.92-7.40235.7KOff
8 May 20265.74 USD45.3%4.24 USD7.13 USD0.571.14711.5KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context